Skip to main content
. 2015 Oct 23;5(4):2854–2876. doi: 10.3390/biom5042854

Figure 2.

Figure 2

Functional interplay between wild-type p53 and mutant p53. Mutant p53 acts as a dominant-negative inhibitor against wild-type p53 and then contributes to carcinogenesis and drug-resistance.